Literature DB >> 1822251

Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure.

I T Meredith1, M D Esler, H S Cox, G W Lambert, G L Jennings, G Eisenhofer.   

Abstract

Primary autonomic failure is a heterogenous group of diseases with evidence for lesions in both the central and peripheral elements of the autonomic nervous system. We determined the extent of peripheral sympathetic dysfunction in six patients with primary autonomic failure without clinical evidence of central nervous system involvement (pure autonomic failure) using biochemical methods for studying regional noradrenaline spillover and removal. The results were compared with those from 14 age-matched normal subjects, seven of whom were studied before and after pharmacological neuronal uptake-blockade with desipramine. Total, cardiac and renal noradrenaline spillover to plasma were 78%, 98% and 66% lower respectively in pure autonomic failure than in normal subjects (p less than 0.001). Total noradrenaline plasma clearance was 20% lower in pure autonomic failure (p less than 0.005) than in normal subjects and similar to the level observed in normal subjects following neuronal noradrenaline uptake-blockade with desipramine, mean transcardiac extraction of tritiated noradrenaline was 74% in normal subjects and 20% in pure autonomic failure, identical to the value post-desipramine in normal subjects. Cardiac spillover of the noradrenaline precursor, dihydroxyphenylanine, and the primary intra-neuronal metabolite dihydroxyphenylglycol, were 78% and 94% lower respectively in pure autonomic failure than in normal subjects (p less than 0.001). These data indicate a marked reduction in the apparent release rate and neuronal uptake of noradrenaline in the hearts of patients with pure autonomic failure, and provide biochemical evidence of almost total postganglionic sympathetic denervation in this condition.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822251     DOI: 10.1007/BF01824986

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  30 in total

1.  A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study.

Authors:  G M SHY; G A DRAGER
Journal:  Arch Neurol       Date:  1960-05

Review 2.  Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover.

Authors:  M Esler; G Jennings; P Korner; I Willett; F Dudley; G Hasking; W Anderson; G Lambert
Journal:  Hypertension       Date:  1988-01       Impact factor: 10.190

3.  Plasma levels of catechols after fasting in intact or adrenal-demedullated rats.

Authors:  M Garty; A Deka-Starosta; R Stull; I J Kopin; D S Goldstein
Journal:  J Auton Nerv Syst       Date:  1989-03

4.  Measurement of coronary sinus blood flow by continuous thermodilution in man.

Authors:  W Ganz; K Tamura; H S Marcus; R Donoso; S Yoshida; H J Swan
Journal:  Circulation       Date:  1971-08       Impact factor: 29.690

5.  Disorders of the autonomic nervous system: Part 1. Pathophysiology and clinical features.

Authors:  J G McLeod; R R Tuck
Journal:  Ann Neurol       Date:  1987-05       Impact factor: 10.422

6.  Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans.

Authors:  G Eisenhofer; J E Brush; R O Cannon; R Stull; I J Kopin; D S Goldstein
Journal:  J Clin Endocrinol Metab       Date:  1989-02       Impact factor: 5.958

7.  Norepinephrine depletion in idiopathic orthostatic hypotension.

Authors:  H A Kontos; D W Richardson; J E Norvell
Journal:  Ann Intern Med       Date:  1975-03       Impact factor: 25.391

8.  Neuronal re-uptake of noradrenaline by sympathetic nerves in humans.

Authors:  G Eisenhofer; M D Esler; I T Meredith; C Ferrier; G Lambert; G Jennings
Journal:  Clin Sci (Lond)       Date:  1991-03       Impact factor: 6.124

9.  Increased plasma dihydroxyphenylalanine during sympathetic activation in humans is related to increased norepinephrine turnover.

Authors:  G Eisenhofer; I T Meredith; C Ferrier; H S Cox; G Lambert; G L Jennings; M D Esler
Journal:  J Lab Clin Med       Date:  1991-04

10.  In vivo measurement of neuronal uptake of norepinephrine in the human heart.

Authors:  D S Goldstein; J E Brush; G Eisenhofer; R Stull; M Esler
Journal:  Circulation       Date:  1988-07       Impact factor: 29.690

View more
  10 in total

1.  An explanation of the unexpected efficacy of L-DOPS in pure autonomic failure.

Authors:  Murray Esler
Journal:  Clin Auton Res       Date:  2004-12       Impact factor: 4.435

2.  Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.

Authors:  Claudia E Ramirez; Luis E Okamoto; Amy C Arnold; Alfredo Gamboa; André Diedrich; Leena Choi; Satish R Raj; David Robertson; Italo Biaggioni; Cyndya A Shibao
Journal:  Hypertension       Date:  2014-09-02       Impact factor: 10.190

Review 3.  The sympathetic nervous system in hypertension: back to the future?

Authors:  Murray Esler
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

4.  Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure.

Authors:  J J van Lieshout; A D ten Harkel; W Wieling
Journal:  Clin Auton Res       Date:  2000-02       Impact factor: 4.435

Review 5.  Sympathetic nerve function--assessment by radioisotope dilution analysis.

Authors:  Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

Review 6.  Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.

Authors:  David S Goldstein; Risa Isonaka; Guillaume Lamotte; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2021-10-20       Impact factor: 4.435

Review 7.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

8.  Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans.

Authors:  David A Mitchell; Gavin Lambert; Niels H Secher; Peter B Raven; Johannes van Lieshout; Murray D Esler
Journal:  J Physiol       Date:  2009-04-29       Impact factor: 5.182

Review 9.  Pure Autonomic Failure.

Authors:  Pariwat Thaisetthawatkul
Journal:  Curr Neurol Neurosci Rep       Date:  2016-08       Impact factor: 5.081

Review 10.  Controversies Surrounding Renal Denervation: Lessons Learned From Real-World Experience in Two United Kingdom Centers.

Authors:  Amy E Burchell; Kenneth Chan; Laura E K Ratcliffe; Emma C Hart; Manish Saxena; David J Collier; Ajay K Jain; Anthony Mathur; Charles J Knight; Mark J Caulfield; Julian F R Paton; Angus K Nightingale; Melvin D Lobo; Andreas Baumbach
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-02-09       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.